Determinants of antibody responses to primary courses and booster doses of SARS-CoV-2 vaccines in 9,101 UK adults
D. Jolliffe (London, United Kingdom), S. Faustini (Birmingham, United Kingdom), H. Holt (London, United Kingdom), M. Talaei (London, United Kingdom), G. Vivaldi (London, United Kingdom), A. Richter (Birmingham, United Kingdom), S. Shaheen (London, United Kingdom), A. Martineau (London, United Kingdom)
Source: International Congress 2022 – Vaccination
Session: Vaccination
Session type: Thematic Poster
Number: 1116
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Jolliffe (London, United Kingdom), S. Faustini (Birmingham, United Kingdom), H. Holt (London, United Kingdom), M. Talaei (London, United Kingdom), G. Vivaldi (London, United Kingdom), A. Richter (Birmingham, United Kingdom), S. Shaheen (London, United Kingdom), A. Martineau (London, United Kingdom). Determinants of antibody responses to primary courses and booster doses of SARS-CoV-2 vaccines in 9,101 UK adults. 1116
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|